Potential synergistic effect of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade and hTERT vaccination was investigated in metastatic melanoma in a phase I/IIa clinical trial (28). Here, CTLA4 is linked to metastatic melanoma.